UK markets closed

Bone Therapeutics SA (0R55.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.6700-0.0010 (-0.15%)
At close: 04:10PM GMT
Full screen
Previous close0.6710
Open0.6580
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.6560 - 0.6720
52-week range0.6560 - 0.6720
Volume107
Avg. volumeN/A
Market cap6.848M
Beta (5Y monthly)0.16
PE ratio (TTM)N/A
EPS (TTM)-0.5690
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Bone Therapeutics SA: Transparency notification received from S.R.I.W. SA and Sofipôle SA

    REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Gosselies, Belgium, 23 December 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces that it has received a transparency notification from S.R.I.W. SA (Société Régionale d’Investissement de Wallonie) dated 14 December 2021. The transparency notification indicates that the shareholdin

  • Globe Newswire

    Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV

    REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Gosselies, Belgium, 10 December 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces that it has received a transparency notification dated 8 December 2021 indicating that the shareholdings held by Nyenburgh Holding NV have crossed above the threshold of 5% following the issuance of

  • Globe Newswire

    Bone Therapeutics SA: Information on the total number of voting rights and shares

    REGULATED INFORMATION Gosselies, Belgium, 9 December 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares in a private placement on 2 December 2021. The following information is published in accordance with Article 15 of the Belgian Law of 2 May 2007 on the publication of